Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

In January 2025, Aptose announced the initiation of the TUSCANY trial and dosing in the first cohort of newly-diagnosed AML patients with the lowest starting dose (40 mg) of TUS as part of the ...

Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...

As Vitality becomes the first UK insurance provider to offer discounted weight-loss jab treatment, Yahoo UK spoke to them to ...

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.14. Operator: Hello, and thank you for standing ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...

In the realm of wellness and natural remedies, Tricolla Farms CBD Gummies have emerged as a leading choice for individuals ...

This positive safety profile is crucial for a drug targeting a chronic and severe condition like ... READ NEXT: 20 Best AI ...

The report allowed analysis by pharmacist and type of discontinuation (e.g., dosing adjustment, change in therapy, drug ... to complete a specific intervention. Because patient profile review ...

P-gp and BCRP Substrates: Avoid concomitant use of sensitive substrates of P-gp and BCRP with FILSPARI. Sparsentan may increase exposure of these transporter substrates, which may increase the risk of ...